Connection
Richard Lindrooth to Cost-Benefit Analysis
This is a "connection" page, showing publications Richard Lindrooth has written about Cost-Benefit Analysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.244 |
|
|
|
-
Jayawardhana J, Welton JM, Lindrooth RC. Is there a business case for magnet hospitals? Estimates of the cost and revenue implications of becoming a magnet. Med Care. 2014 May; 52(5):400-6.
Score: 0.093
-
Lindrooth RC, McCullough JS. The effect of Medicaid family planning expansions on unplanned births. Womens Health Issues. 2007 Mar-Apr; 17(2):66-74.
Score: 0.057
-
Whittington MD, Atherly AJ, Curtis DJ, Lindrooth RC, Bradley CJ, Campbell JD. Recommendations for Methicillin-Resistant Staphylococcus aureus Prevention in Adult ICUs: A Cost-Effectiveness Analysis. Crit Care Med. 2017 Aug; 45(8):1304-1310.
Score: 0.029
-
Yakusheva O, Lindrooth R, Weiss M. Economic evaluation of the 80% baccalaureate nurse workforce recommendation: a patient-level analysis. Med Care. 2014 Oct; 52(10):864-9.
Score: 0.024
-
Ellis C, Lindrooth RC, Horner J. Retrospective cost-effectiveness analysis of treatments for aphasia: an approach using experimental data. Am J Speech Lang Pathol. 2014 May; 23(2):186-95.
Score: 0.023
-
Zarkin GA, Lindrooth RC, Demiralp B, Wechsberg W. The cost and cost-effectiveness of an enhanced intervention for people with substance abuse problems at risk for HIV. Health Serv Res. 2001 Jun; 36(2):335-55.
Score: 0.010
-
Lacey L, Mauskopf J, Lindrooth R, Pham S, Saag M, Sawyer W. A prospective cost-consequence analysis of adding lamivudine to zidovudine-containing antiretroviral treatment regimens for HIV infection in the US. Pharmacoeconomics. 1999; 15 Suppl 1:23-37.
Score: 0.008